|
|
|
| home > white papers > Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services - DrugDev |
|
|
 WHITE PAPERS |
|
DrugDev
|
|
Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services
|
|
With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents. Many clinical trials are hindered by inefficient, labor-intensive processes. Prolonged, inefficient activation can hamper investigator satisfaction and, ultimately, have a negative bottom-line impact for sponsors and CROs. In addition, the Sunshine Act is heightening the importance of financial disclosure in clinical trials. Without a robust financial disclosure strategy, sponsors cannot ensure that physician self-reported financial disclosure data are aligned with the payment data being reported through the Sunshine Act, increasing financial and regulatory risk.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
HemaCare and Tissue Solutions Announce Strategic Partnership to Expand Access to Human Disease-State Samples
HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, and Tissue Solutions Ltd, a leading global provider of diseased human biosamples for research, today announced their partnership to supply customers with an expanded selection of well-qualified disease-state biomaterials in fresh, frozen, and FFPE formats.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trials in Ukraine: Orange Paper Overview and 1st Half Year 2014
Synergy Research Group
The Orange Paper is an analytical report about the clinical trials
market in Russia, published quarterly by the contract research
organization Synergy Research Group. The first edition of Orange Paper
was released in 2006, and at the moment 31 issues have already
published. Now, thanks to Synergy Group Ukraine, obtaining information
about the market of clinical trials in Ukraine has become possible.
In
Ukraine, during the period from 1996 to 2013, applicants had obtained
3,864 positive conclusions about the possibility of conducting clinical
trials of drugs, both for domestic and foreign manufacturers, including
conduct of multinational multi-center clinical trials (hereinafter –
MMCTs)
More info >> |
|
 |
Industry Events |
 |
DIA 2019 Global Annual Meeting
23-27 June 2019, San Diego Convention Center
DIA 2019 is more than just a meeting: it’s where
brilliant minds come together to create solutions. Thousands of global
innovators will convene to engage in discussions on today’s hottest topics in
the life sciences field, propose ways to combat daily challenges, and network
to create lasting connections.
More info >> |
|
|
|
